Research on reflux, testis tumors grab headlines at AAP
The endoscopic treatment of vesicoureteral reflux and the pathology oftestis tumors were the subject of both important new research and livelydiscussion during the 2003 American Academy of Pediatrics Section on Urologymeeting. Although many important topics were discussed at what is arguablythe finest annual meeting on pediatric urology in the world, these two subjectsdeserve particular attention and are the focus of articles in this issueof Urology Times.
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.